Reliance, Inc. arrives at Wednesday's Q2 print having fallen back below its analyst consensus mean — a notable shift from earlier this month, when the stock was trading above most targets and the valuation tension was the dominant story.
The price action has done some of the work for the bears. RS is down roughly 2.6% over the past month, closing at $386.21. That now places the stock almost precisely at the Street's mean target of $386.25 — a dead-level alignment that essentially leaves no buffer in either direction heading into the number. Options positioning has remained calm throughout. The put/call ratio is 0.287, barely above its 20-day average of 0.285 and statistically unremarkable at just 0.4 standard deviations above the mean. Call demand still runs ahead of puts, but the bullish tilt flagged in earlier notes has not intensified into the print — options traders are neither hedging aggressively nor pressing the upside.
The debate between bulls and bears comes down to whether Q2 volumes and margins can justify the stock holding near current levels. Keybanc is the outlier on the buy side, lifting its target to $418 with an Overweight rating in late June — it sees room for the stock to re-rate higher. JP Morgan and Wells Fargo, the two most recently active analysts, both trimmed targets in the days before the print to $376 and $372 respectively, maintaining neutral stances. Their message is consistent: the business is fine, but the stock has run ahead of the fundamental case. Earnings-quality factor scores offer some support to the optimists — the EPS surprise rank sits in the 72nd percentile, and the forward EPS growth signal remains strong. Peers and both gained more than 2% on the session, suggesting the sector backdrop into the print is not hostile.
Short interest has ticked up roughly 3% on the week to 1.8% of the float, a small directional move but nothing that changes the structural picture. The lending market remains almost entirely unconstrained — over 50 million shares are available to borrow and borrow costs are just 0.40%. There is no meaningful squeeze pressure here, and the short score of 31.6 is stable and well within the low-risk range.
The print therefore tests a narrow question: whether Q2 results are strong enough to pull analyst targets back above the current price, or confirm that the recent slide has simply brought the stock back to where the Street already thought it belonged.
See the live data behind this article on ORTEX.
Open RS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
